[
  {
    "ts": null,
    "headline": "VIG May Be Poised To Outperform FDVV In 2026",
    "summary": "Compare VIG vs. FDVV ETF performance and explore why Vanguard Dividend Appreciation Index Fund ETF Shares' (VIG) sector focus means 2026 upside.",
    "url": "https://finnhub.io/api/news?id=738e6ba07f0dbdd8905da82974a7cce56d62259f98ce3a74ceff2811f8920e9f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767136961,
      "headline": "VIG May Be Poised To Outperform FDVV In 2026",
      "id": 137945783,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2244450943/image_2244450943.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "Compare VIG vs. FDVV ETF performance and explore why Vanguard Dividend Appreciation Index Fund ETF Shares' (VIG) sector focus means 2026 upside.",
      "url": "https://finnhub.io/api/news?id=738e6ba07f0dbdd8905da82974a7cce56d62259f98ce3a74ceff2811f8920e9f"
    }
  },
  {
    "ts": null,
    "headline": "Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference",
    "summary": "GENEVA, December 30, 2025--Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.",
    "url": "https://finnhub.io/api/news?id=15e111025779dbd3f76d0a1523b709d920c25a2afea0a0b3c3e9aa2224133334",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767130200,
      "headline": "Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference",
      "id": 137950151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "GENEVA, December 30, 2025--Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.",
      "url": "https://finnhub.io/api/news?id=15e111025779dbd3f76d0a1523b709d920c25a2afea0a0b3c3e9aa2224133334"
    }
  },
  {
    "ts": null,
    "headline": "Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Stand",
    "url": "https://finnhub.io/api/news?id=b1e5a77538414a46af3131d4e74ebf2e7a4a2fc0f9181524cf63bad486dd2bd6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767128700,
      "headline": "Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137950155,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Stand",
      "url": "https://finnhub.io/api/news?id=b1e5a77538414a46af3131d4e74ebf2e7a4a2fc0f9181524cf63bad486dd2bd6"
    }
  },
  {
    "ts": null,
    "headline": "Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Adaptive Biotechnologies’ management is scheduled to present on Monday, January 12, 2026, at 4:30 p.m. Pacific Time /",
    "url": "https://finnhub.io/api/news?id=531d30a944cd9feeb198ef5859b0eb5aa979b7ec6045b0ff6640792a755adb15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767128700,
      "headline": "Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137949722,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Adaptive Biotechnologies’ management is scheduled to present on Monday, January 12, 2026, at 4:30 p.m. Pacific Time /",
      "url": "https://finnhub.io/api/news?id=531d30a944cd9feeb198ef5859b0eb5aa979b7ec6045b0ff6640792a755adb15"
    }
  },
  {
    "ts": null,
    "headline": "TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "TransMedics Group, Inc. (\"TransMedics\") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, at 3:00 pm Pacific Standard Time / 6:00 pm Eastern Standard Time.",
    "url": "https://finnhub.io/api/news?id=bf8e90d094139263149b839ba1a1bfa55c2aaff55f68d3507f5a7fea3192894c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767128700,
      "headline": "TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137950153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "TransMedics Group, Inc. (\"TransMedics\") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, at 3:00 pm Pacific Standard Time / 6:00 pm Eastern Standard Time.",
      "url": "https://finnhub.io/api/news?id=bf8e90d094139263149b839ba1a1bfa55c2aaff55f68d3507f5a7fea3192894c"
    }
  },
  {
    "ts": null,
    "headline": "PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for",
    "url": "https://finnhub.io/api/news?id=1f844b256c0a0e37944acd1246169ff71b6ce9e21fb07fe073ce91584f4a0fe8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767128700,
      "headline": "PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137950152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for",
      "url": "https://finnhub.io/api/news?id=1f844b256c0a0e37944acd1246169ff71b6ce9e21fb07fe073ce91584f4a0fe8"
    }
  },
  {
    "ts": null,
    "headline": "Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "DUBLIN, December 30, 2025--Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST (1:30 p.m. EST/6:30 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.",
    "url": "https://finnhub.io/api/news?id=8c56de35a46198a37d505279140b398bdcd777b4b31ed9fec170664118ed2e81",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767128400,
      "headline": "Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137950156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "DUBLIN, December 30, 2025--Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST (1:30 p.m. EST/6:30 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.",
      "url": "https://finnhub.io/api/news?id=8c56de35a46198a37d505279140b398bdcd777b4b31ed9fec170664118ed2e81"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street's most stressful hiring ritual may be about to restart",
    "summary": "PE firms respected Dimon's on-cycle recruiting moratorium in 2025. When the clock strikes midnight on Jan 1, it seems the practice might ramp back up.",
    "url": "https://finnhub.io/api/news?id=b46ea11a0946482b59d4fe7b43d3b40eb887c5e30a5d7f37ffc0042c36c34312",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767121081,
      "headline": "Wall Street's most stressful hiring ritual may be about to restart",
      "id": 137943918,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "PE firms respected Dimon's on-cycle recruiting moratorium in 2025. When the clock strikes midnight on Jan 1, it seems the practice might ramp back up.",
      "url": "https://finnhub.io/api/news?id=b46ea11a0946482b59d4fe7b43d3b40eb887c5e30a5d7f37ffc0042c36c34312"
    }
  },
  {
    "ts": null,
    "headline": "Bank stocks: 3 themes to watch in 2026",
    "summary": "Shortly after the new year, banks will start reporting their quarterly earnings, with JPMorgan Chase (JPM) releasing its fourth quarter results on Tuesday, Jan. 13. Christopher McGratty, head of US bank research at KBW, a Stifel company, shares what he will be watching for from banks in 2026. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=b3106bbd1f87efca518103f2016184f283cd585a0611affea5dbb8d0091373cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767114809,
      "headline": "Bank stocks: 3 themes to watch in 2026",
      "id": 137941910,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Shortly after the new year, banks will start reporting their quarterly earnings, with JPMorgan Chase (JPM) releasing its fourth quarter results on Tuesday, Jan. 13. Christopher McGratty, head of US bank research at KBW, a Stifel company, shares what he will be watching for from banks in 2026. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=b3106bbd1f87efca518103f2016184f283cd585a0611affea5dbb8d0091373cc"
    }
  },
  {
    "ts": null,
    "headline": "Here is What to Know Beyond Why JPMorgan Chase & Co. (JPM) is a Trending Stock",
    "summary": "JPMorgan Chase & Co. (JPM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=aab3e4229790d3917c837f7d1cbb4c679aa73796aa9e48bf1f77bdd5021d4d86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767103203,
      "headline": "Here is What to Know Beyond Why JPMorgan Chase & Co. (JPM) is a Trending Stock",
      "id": 137941911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan Chase & Co. (JPM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=aab3e4229790d3917c837f7d1cbb4c679aa73796aa9e48bf1f77bdd5021d4d86"
    }
  },
  {
    "ts": null,
    "headline": "South Korea Stocks Cap Strongest Rally in 25 Years as Kospi Surges 76%",
    "summary": "The Kospi outperformed global peers in 2025, led by chips, defense, nuclear power and K-beauty stocks.",
    "url": "https://finnhub.io/api/news?id=6e5aa38ecc880099e2cfd215460546c1cdc4e3c50bd65d9a26b07c88f470307a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767102473,
      "headline": "South Korea Stocks Cap Strongest Rally in 25 Years as Kospi Surges 76%",
      "id": 137940253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The Kospi outperformed global peers in 2025, led by chips, defense, nuclear power and K-beauty stocks.",
      "url": "https://finnhub.io/api/news?id=6e5aa38ecc880099e2cfd215460546c1cdc4e3c50bd65d9a26b07c88f470307a"
    }
  },
  {
    "ts": null,
    "headline": "GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference",
    "summary": "GAITHERSBURG, Md., December 30, 2025--GeneDx announced that company management will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15 in San Francisco.",
    "url": "https://finnhub.io/api/news?id=b4ccf7bad489866c78e0832b99142b17c1549b38cfa6021f1b50cfd3c4e4afa9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767099600,
      "headline": "GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference",
      "id": 137940254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "GAITHERSBURG, Md., December 30, 2025--GeneDx announced that company management will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15 in San Francisco.",
      "url": "https://finnhub.io/api/news?id=b4ccf7bad489866c78e0832b99142b17c1549b38cfa6021f1b50cfd3c4e4afa9"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Chase Is Getting New Strategic Leadership, Courtesy of Berkshire Hathaway",
    "summary": "The financial services powerhouse has appointed Todd Combs to lead a key initiative.",
    "url": "https://finnhub.io/api/news?id=a730fb5d6338603e4ef35513bc5b6d15933a106fe0be2c109b257cb14716a8d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767092700,
      "headline": "JPMorgan Chase Is Getting New Strategic Leadership, Courtesy of Berkshire Hathaway",
      "id": 137940255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The financial services powerhouse has appointed Todd Combs to lead a key initiative.",
      "url": "https://finnhub.io/api/news?id=a730fb5d6338603e4ef35513bc5b6d15933a106fe0be2c109b257cb14716a8d4"
    }
  },
  {
    "ts": null,
    "headline": "Chase Freedom Unlimited's limited-time $300 bonus and rewards make it a great starter card for 2026",
    "summary": "Don't let the cash back label trick you; the Freedom Unlimited offers much more when paired with a premium Chase card.",
    "url": "https://finnhub.io/api/news?id=fc846a39d4e8496d8f3dc002a2cf2d9ee2b205a7407e654935c55e81bdc1f353",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767088562,
      "headline": "Chase Freedom Unlimited's limited-time $300 bonus and rewards make it a great starter card for 2026",
      "id": 137941553,
      "image": "https://image.cnbcfm.com/api/v1/image/108245615-1766588318073-gettyimages-82562887-sp000147.jpeg?v=1766588330&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "Don't let the cash back label trick you; the Freedom Unlimited offers much more when paired with a premium Chase card.",
      "url": "https://finnhub.io/api/news?id=fc846a39d4e8496d8f3dc002a2cf2d9ee2b205a7407e654935c55e81bdc1f353"
    }
  },
  {
    "ts": null,
    "headline": "5 Dividends A Year Pour In From First National Bank Alaska",
    "summary": "First National Bank Alaska stock offers a 6.8% yield, strong growth, and fair value. Here's what dividend investors need to know.",
    "url": "https://finnhub.io/api/news?id=169e50b20f3fd91b50002b62e20deb493be699ec70dc418b6303e87025979576",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767081600,
      "headline": "5 Dividends A Year Pour In From First National Bank Alaska",
      "id": 137939294,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194611507/image_2194611507.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "First National Bank Alaska stock offers a 6.8% yield, strong growth, and fair value. Here's what dividend investors need to know.",
      "url": "https://finnhub.io/api/news?id=169e50b20f3fd91b50002b62e20deb493be699ec70dc418b6303e87025979576"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs, JPMorgan Lead Wall Street’s M&A League Tables",
    "summary": "JPMorgan and Goldman Sachs proved they’re still the go-to middlemen for Wall Street deals amid a near-record $4.8 trillion global M&A bonanza",
    "url": "https://finnhub.io/api/news?id=9f658db380d80dd1a88294efcb95c640316d4010cdb82ec8e89ec87704498858",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767070860,
      "headline": "Goldman Sachs, JPMorgan Lead Wall Street’s M&A League Tables",
      "id": 137940257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan and Goldman Sachs proved they’re still the go-to middlemen for Wall Street deals amid a near-record $4.8 trillion global M&A bonanza",
      "url": "https://finnhub.io/api/news?id=9f658db380d80dd1a88294efcb95c640316d4010cdb82ec8e89ec87704498858"
    }
  },
  {
    "ts": null,
    "headline": "Bubble Worries Fail to Break Wall Street’s Gold Dust Fever",
    "summary": "Forecasters predict gold's rally will stretch through December 2026, although one analysis says there's reason for caution.",
    "url": "https://finnhub.io/api/news?id=0cc9855559e77ce5bc0c25b04eaf344e25215c025f24d0bc8bac9c4966b6d179",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767070860,
      "headline": "Bubble Worries Fail to Break Wall Street’s Gold Dust Fever",
      "id": 137940256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Forecasters predict gold's rally will stretch through December 2026, although one analysis says there's reason for caution.",
      "url": "https://finnhub.io/api/news?id=0cc9855559e77ce5bc0c25b04eaf344e25215c025f24d0bc8bac9c4966b6d179"
    }
  },
  {
    "ts": null,
    "headline": "Hideout in the Financial Sector as We Round out 2025?",
    "summary": "Entering the last trading week of the year, investors are certainly pondering where to put their money to work in 2026, and the financial sector may be at the forefront with the stock market near all-time highs.",
    "url": "https://finnhub.io/api/news?id=8dcef7fefb1aa033766e6985624f2f86137db53056956e4583638ff293265554",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767057360,
      "headline": "Hideout in the Financial Sector as We Round out 2025?",
      "id": 137940259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Entering the last trading week of the year, investors are certainly pondering where to put their money to work in 2026, and the financial sector may be at the forefront with the stock market near all-time highs.",
      "url": "https://finnhub.io/api/news?id=8dcef7fefb1aa033766e6985624f2f86137db53056956e4583638ff293265554"
    }
  }
]